IL15 and cranioectodermal dysplasia: Much of the data we have on effects of IL-15 on IEL have been derived from CeD patients and from ‘healthy’ IEL obtained from oesophagus-gastro-duodenoscopies for non-CeD complaints, or from gastric bypasses for morbidly obese patients11–13.